Escitalopram vs placebo
- Early pharmacological interventions for prevention of post‐traumatic stress disorder (PTSD) in individuals… 2024 · Cochrane Headline outcomes onlyno estimate extracted1 study · 31 participantsVery low
Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.
It is very uncertain whether escitalopram changes PTSD rate at 3 months compared with placebo (very low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Hydrocortisone showed no clear difference in dropouts due to adverse events at 3 months compared with placebo (low certainty).
It is very uncertain whether hydrocortisone changes PTSD rate at 3 months compared with placebo (very low certainty).
The review found no eligible studies for this question.
Summary of findings ‐ Erector spinae plane block showed no clear difference in rates of block‐related adverse events compared with placebo block (low certainty).
It is very uncertain whether summary of findings table ‐ Vitamin B12 supplementation changes maternal anaemia compared with placebo/no vitamin B12 supplementation (very low certainty).
It is very uncertain whether summary of findings table ‐ Vitamin B12 supplementation changes maternal vitamin B12 deficiency compared with placebo/no vitamin B12 supplementation (very low certainty).
Summary of findings table ‐ Vitamin B12 supplementation showed no clear difference in low birthweight (< 2500 g) compared with placebo/no vitamin B12 supplementation (low certainty).
Summary of findings table ‐ Vitamin B12 supplementation showed no clear difference in preterm birth (< 37 weeks) compared with placebo/no vitamin B12 supplementation (low certainty).
The review found no eligible studies for this question.
Intrauterine infusion/injection of autologous platelet‐rich plasma may leads to higher adverse events: preterm delivery compared with no intervention or placebo (low certainty).
It is very uncertain whether intrauterine infusion/injection of autologous platelet‐rich plasma changes live birth (or ongoing pregnancy) compared with no intervention or placebo (very low certainty).
It is very uncertain whether intrauterine infusion/injection of autologous platelet‐rich plasma changes miscarriage compared with no intervention or placebo (very low certainty).